In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.
There are many opportunities available in the international markets that never make the news in the US. The VEA and VWO ETFs ...
When celebrities reveal their experiences with newer weight-loss drugs, there are upsides and downsides for patients and ...
Six percent of Americans have used Ozempic, Wegovy and similar drugs. They’re unwitting experimental subjects.
Criminals are targeting pharmacies and stealing weight-loss medication in a country with body image insecurities and where ...
The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...
A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.
Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.
We recently compiled a list of the 13 Best Foreign Dividend Stocks To Buy According to Analysts. In this article, we are ...
In this article, we discuss 13 Best Foreign Dividend Stocks To Buy According to Analysts.
Researchers at the University of North Carolina found that a once-weekly injection of Ozempic could cut cravings at its ...
Novo Nordisk A/S failed to convince a federal judge that a pharmacy in Florida making compounded versions of its diabetes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results